You are here
Articles
We selected the best and relevant articles especially for you
Second-line treatment in patients with pancreatic ductal adenocarcinoma: A meta-analysis.
Sonbol MB, Firwana B, Wang Z, Almader-Douglas D, Borad MJ, Makhoul I, Ramanathan RK, Ahn DH, Bekaii-Saab T.
Cancer. 2017 Dec 1;123(23):4680-4686.Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.
Wang-Gillam A, Li CP, Bodoky G, Dean A, Shan YS, Jameson G, Macarulla T, Lee KH, Cunningham D, Blanc JF, Hubner RA, Chiu CF, Schwartsmann G, Siveke JT, Braiteh F, Moyo V, Belanger B, Dhindsa N, Bayever E, Von Hoff DD, Chen LT; NAPOLI-1 Study Group.
Lancet. 2016 Feb 6;387(10018):545-57.Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, Seay T, Tjulandin SA, Ma WW, Saleh MN, Harris M, Reni M, Dowden S, Laheru D, Bahary N, Ramanathan RK, Tabernero J, Hidalgo M, Goldstein D, Van Cutsem E, Wei X, Iglesias J, Renschler MF.
N Engl J Med. 2013 Oct 31;369(18):1691-703.FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Gourgou-Bourgade S, de la Fouchardière C, Bennouna J, Bachet JB, Khemissa-Akouz F, Péré-Vergé D, Delbaldo C, Assenat E, Chauffert B, Michel P, Montoto-Grillot C, Ducreux
N Engl J Med. 2011 May 12;364(19):1817-25.A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis.
Ahn DH, Krishna K, Blazer M, Reardon J, Wei L, Wu C, Ciombor KK, Noonan AM, Mikhail S, Bekaii-Saab
Ther Adv Med Oncol. 2017 Feb;9(2):75-82.Adjuvant therapy for pancreas cancer in an era of value based cancer care.
Ahn DH, Williams TM, Goldstein DA, El-Rayes B, Bekaii-Saab T.
Cancer Treat Rev. 2016 Jan;42:10-7. doi: 10.1016/j.ctrv.2015.11.004. Epub 2015 Nov 24. Review.
Tanios Bekaii-Saab, MD, FACP
Professor, Mayo Clinic College of Medicine and Science
Program Co-Leader, GI Cancer, Mayo Clinic Cancer Center
Senior Associate Consultant, Mayo Clinic AZ , USA
